Source: Journal of Pharmacy and Pharmacology. Unidades: FMRP, FCFRP
Subjects: DIABETES MELLITUS, FARMACOCINÉTICA, ANALGÉSICOS, DOR, NEUROPATIAS DIABÉTICAS
ABNT
MORAES, Natália Valadares de e LAURETTI, Gabriela Rocha e LANCHOTE, Vera Lúcia. Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers. Journal of Pharmacy and Pharmacology, v. 66, n. 9, p. 1222–1230, 2014Tradução . . Disponível em: https://doi.org/10.1111/jphp.12255. Acesso em: 26 abr. 2024.APA
Moraes, N. V. de, Lauretti, G. R., & Lanchote, V. L. (2014). Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers. Journal of Pharmacy and Pharmacology, 66( 9), 1222–1230. doi:10.1111/jphp.12255NLM
Moraes NV de, Lauretti GR, Lanchote VL. Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers [Internet]. Journal of Pharmacy and Pharmacology. 2014 ; 66( 9): 1222–1230.[citado 2024 abr. 26 ] Available from: https://doi.org/10.1111/jphp.12255Vancouver
Moraes NV de, Lauretti GR, Lanchote VL. Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers [Internet]. Journal of Pharmacy and Pharmacology. 2014 ; 66( 9): 1222–1230.[citado 2024 abr. 26 ] Available from: https://doi.org/10.1111/jphp.12255